Clorox (NYSE:CLX) Announces Quarterly Earnings Results

Clorox (NYSE:CLX) announced its earnings results on Monday. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.16, RTT News reports. Clorox had a return on equity of 316.08% and a net margin of 4.78%. During the same quarter in the previous year, the firm posted $2.16 EPS. Clorox updated its FY 2025 guidance to 6.950-7.350 EPS.

Clorox Stock Performance

Clorox stock traded up $1.12 during midday trading on Monday, hitting $159.80. 2,593,906 shares of the company were exchanged, compared to its average volume of 1,136,242. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. Clorox has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The business has a fifty day simple moving average of $162.76 and a two-hundred day simple moving average of $158.50. The firm has a market capitalization of $19.78 billion, a PE ratio of 55.68, a price-to-earnings-growth ratio of 2.92 and a beta of 0.42.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 3.05%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is 170.04%.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the company. DA Davidson raised their price objective on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research report on Thursday. Evercore ISI lowered their price objective on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. JPMorgan Chase & Co. raised their price objective on Clorox from $167.00 to $171.00 and gave the stock a “neutral” rating in a research report on Thursday, January 16th. Finally, Barclays lowered their price objective on Clorox from $139.00 to $130.00 and set an “underweight” rating for the company in a research report on Friday, January 17th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $156.07.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.